| Category |
12/2019 to 6/2020 |
2022 |
2023 |
2024 |
2025 |
| Total number of samples tested |
304 |
819 |
481 |
2,290 |
2,587 |
| Number of samples positive for extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales / Number of samples tested for ESBL-producing Enterobacterales |
42/304 (13.8%) |
29/300 (9.7%) |
18/200 (9.0%) |
165/1,892 (8.7%) |
120/2184 (5.5%) |
| Number of samples positive for carbapenemase-producing Enterobacterales / Number of samples tested for carbapenemase-producing Enterobacterales |
1/304 (0.3%) |
8/496 (1.6%) |
1/304 (0.3%) |
2/2,043 (0.1%) |
5/2333 (0.2%) |
| Number of samples positive for vancomycin-resistant Enterococcus / Number of samples tested for vancomycin-resistant Enterococcus |
0/304 (0%) |
1/719 (0.1%) |
0/381 (0%) |
0/572 (0%) |
0/527 (0%) |
| Total number of samples positive for at least one of the above resistant organisms |
43 |
38 |
19 |
166 |
125 |